David Setboun
Plus aucun poste en cours
Profil
David Setboun served as the Chief Operating Officer & Executive Vice President at Brainstorm Cell Therapeutics, Inc. from 2020 to 2023.
Prior to that, he was the Vice President-Europe at AstraZeneca LP from 2002 to 2009, and the President at Biogen France SAS from 2015 to 2018.
He also served as the President at Astrazeneca Produtos Farmaceuticos Ltda from 2012 to 2015, and as the VP-Corporate Development, Strategy & Business at Life Biosciences, Inc. from 2018 to 2020.
Dr. Setboun holds a doctorate degree from Université de Paris XI Paris Sud, an MBA from École des Hautes Études Commerciales de Paris, and an undergraduate degree from Harvard Business School.
Anciens postes connus de David Setboun
| Sociétés | Poste | Fin |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Directeur des opérations | 31/05/2023 |
Life Biosciences, Inc.
 Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/04/2020 |
Biogen France SAS
 Biogen France SAS BiotechnologyHealth Technology Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France. | President | 01/06/2018 |
| Astrazeneca Produtos Farmaceuticos Ltda | President | 01/01/2015 |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Corporate Officer/Principal | 01/01/2009 |
Formation de David Setboun
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
| Harvard Business School | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
| Université de Paris XI Paris Sud | Consumer Services |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Biogen France SAS
Biogen France SAS BiotechnologyHealth Technology Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France. | Health Technology |
| Astrazeneca Produtos Farmaceuticos Ltda | |
Life Biosciences, Inc.
Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA. | Electronic Technology |
